COMPARISON OF INTRA-ARTICULAR SHAM AND VEHICLE INJECTION FROM A PHASE 2B TRIAL OF SM04690, A SMALL-MOLECULE WNT INHIBITOR, FOR KNEE OSTEOARTHRITIS

被引：1

作者：

Yazici, Y. ^{[1
]}

Tambiah, J. ^{[1
]}

Swearingen, C. ^{[1
]}

Kennedy, S. ^{[1
]}

Strand, V. ^{[2
]}

Cole, B. ^{[3
]}

Hochberg, M. ^{[4
]}

Bannuru, R. ^{[5
]}

McAlindon, T. ^{[5
]}

机构：

[1] Samumed, San Diego, CA USA

[2] Stanford Univ, Sch Med, Stanford, CA 94305 USA

[3] Rush Univ, Midwest Orthopaed, Chicago, IL 60612 USA

[4] Univ Maryland, Baltimore, MD 21201 USA

[5] Tufts Univ, Med Ctr, Boston, MA 02111 USA

来源：

OSTEOARTHRITIS AND CARTILAGE | 2019年 / 27卷

关键词：

D O I：

10.1016/j.joca.2019.02.605

中图分类号：

R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];

学科分类号：

摘要：

340

引用

页码：S241 / S242

页数：2

共 50 条

[21] LORECIVIVINT (SM04690), AN INTRA-ARTICULAR, SMALL-MOLECULE CLK/DYRK INHIBITOR THAT MODULATES THE WNT PATHWAY, PROVIDED CARTILAGEPROTECTIVE EFFECTS IN AN ANIMAL MODEL OF POSTTRAUMATIC OA
Seo, T.
Deshmukh, V.
Yazici, Y.
OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S297 - S298
[22] The Novel, Intra-articular CLK/DYRK1A Inhibitor Lorecivivint (LOR; SM04690), Which Modulates the Wnt Pathway, Improved Responder Outcomes in Subjects with Knee Osteoarthritis: A Post Hoc Analysis from a Phase 2b Trial
Yazici, Yusuf
Kennedy, Sarah
Swearingen, Chris
Tambiah, Jeyanesh
ARTHRITIS & RHEUMATOLOGY, 2019, 71
[23] Intra-articular injection of a novel Wnt pathway inhibitor, SM04690, upregulates Wnt16 expression and reduces disease progression in temporomandibular joint osteoarthritis
Hua, Bingqiang
Qiu, Jin
Ye, Xiaoping
Liu, Xianwen
BONE, 2022, 158
[24] THE NOVEL, INTRA-ARTICULAR CLK/DYRK1A INHIBITOR LORECIVIVINT (LOR; SM04690), WHICH MODULATES THE WNT PATHWAY, IMPROVED RESPONDER OUTCOMES IN SUBJECTS WITH KNEE OSTEOARTHRITIS: A POST HOC ANALYSIS FROM A PHASE 2B TRIAL
Yazici, Y.
Kennedy, S.
Swearingen, C.
Tambiah, J.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 809 - 810
[25] ANTI-INFLAMMATORY PROPERTIES OF SM04690, A SMALL MOLECULE INHIBITOR OF THE WNT PATHWAY AS A POTENTIAL TREATMENT FOR KNEE OSTEOARTHRITIS
Deshmukh, V.
Barroga, C.
Ibanez, M.
Seo, T.
Kc, S.
Dellamary, L.
Stewart, J.
Yazici, Y.
OSTEOARTHRITIS AND CARTILAGE, 2017, 25 : S310 - S311
[26] THE NOVEL, INTRA-ARTICULAR CLK/DYRK1A INHIBITOR LORECIVIVINT (LOR; SM04690), WHICH MODULATES THE WNT PATHWAY, IMPROVED RESPONDER OUTCOMES IN SUBJECTS WITH KNEE OSTEOARTHRITIS: A POST HOC ANALYSIS FROM A PHASE 2B TRIAL
Yazici, Yusuf
Kennedy, Sarah
Swearingen, Christopher I.
Tambiah, Jeyanesh
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 120 - 121
[27] ANTI-INFLAMMATORY PROPERTIES OF SM04690, A SMALL MOLECULE INHIBITOR OF THE WNT PATHWAY AS A POTENTIAL TREATMENT FOR KNEE OSTEOARTHRITIS
Deshmukh, V.
Barroga, C.
Ibanez, M.
Seo, T.
Kc, S.
Yazici, Y.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 984 - 984
[28] Assessment of Health-Related Quality of Life in a 52-Week, Phase 2, Randomized, Controlled Trial of a Novel, Intra-Articular, Wnt Pathway Inhibitor (SM04690) for Treatment of Knee Osteoarthritis
Strand, Vibeke
Ghandehari, Heli
Swearingen, Christopher
Tambiah, Jeyanesh
ARTHRITIS & RHEUMATOLOGY, 2018, 70
[29] Radiographic Outcomes from a Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study of a Novel, Intra-Articular, Injectable, Wnt Inhibitor (SM04690) in the Treatment of Osteoarthritis of the Knee
Swearingen, Christopher J.
Majumdar, Sharmila
Simsek, Ismail
DiFrancesco, Anita
Tambiah, Jeymi
Yazici, Yusuf
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[30] RESULTS FROM A 52-WEEK RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDYOFA NOVEL, INTRA-ARTICULAR WNT PATHWAY INHIBITOR (SM04690) FOR THE TREATMENT OF KNEE OSTEOARTHRITIS
Yazici, Y.
McAlindon, T.
Gibofsky, A.
Lane, N.
Clauw, D.
Grifman, M.
Swearingen, C.
DiFrancesco, A.
Tambiah, J.
Hochberg, M.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S137 - S137

← 1 2 3 4 5 →